Eiger BioPharmaceuticals to focus Avexitide for hyperinsulinemic hypoglycaemia indications
Eiger BioPharmaceuticals has revealed it will focus its development efforts on advancing avexitide in hyperinsulinemic hypoglycaemia...
top of page
Browse by category
Search
NICE needs more evidence before recommending tirzepatide for T2DM treatment
The UK’s National Institute for Health and Care Excellence (NICE) has not recommended tirzepatide (Mounjaro, developed by Eli Lilly) in...
ReShape submits PMA to FDA for next-generation lap-band 2.0
ReShape Lifesciences has submitted a Premarket Approval (PMA) supplement application to the FDA for the company’s next generation,...
Allurion and Medtronic to expand access to AI-powered weight loss programme
Allurion has entered a pilot collaboration agreement with Medtronic, to expand access to Allurion’s AI-powered weight loss programme...
Novo Nordisk to protect US patients from unlawful sales of non-FDA approved ‘semaglutide medicines’
Novo Nordisk is taking multiple actions to protect US patients from the unlawful marketing and sales of non-FDA approved counterfeit and...
Innova Care Concepts’ Interlude 500 ultra-low bariatric care bed now incorporates VersaDrive
Innova Care Concepts has revealed that its Interlude 500 ultra-low bariatric care bed will now incorporate the VersaDrive, a unique...
Rhythm gains Health Canada Approval of IMCIVREE setmelanotide injection for weight management
Health Canada has approved Rhythm Pharmaceuticals’ IMCIVREE (setmelanotide solution for subcutaneous injection) for weight management in...
Olympus launches POWERSEAL Sealer/Divider, a next level surgical bipolar energy device in EMEA
Olympus has announced the full market launch of POWERSEAL Sealer/Divider for the Europe, Middle East and Africa (EMEA) region. This...
Fractyl initiates Global Registry Study of the Revita System
Fractyl Health has initiated its Revita Global Registry Program, in which registry subjects will initially enrol in multiple hospitals in...
ReShape gains receives US patent for Obalon Balloon System
ReShape Lifesciences has received a Notice of Allowance from the US Patent and Trademark Office (USPTO) for patent application...
Browse by tag
bottom of page